Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

In vitro and in vivo characterization of new KDR inhibitors disclosed by Merck

Aug. 21, 2002

Merck reports novel KDR inhibitors at ACS meeting

Aug. 21, 2002

Results on FTase inhibitor SCH-400 presented at ACS

Aug. 21, 2002

OSI and Genentech update progress of Tarceva development program

Aug. 21, 2002

Antioxidant epicatechin derivatives for use in cancer, cardiovascular disorders, etc.

Aug. 21, 2002

Abbott reports novel HDAC inhibitors at the ACS meeting

Aug. 20, 2002

Ras-MAPK signaling cascade inhibitors prepared and tested at Wyeth

Aug. 20, 2002

Potent, selective and orally bioavailable FTase inhibitor presented by Abbott

Aug. 20, 2002

Iressa NSCLC trial results show no improvement in combined treatment with standard chemotherapy

Aug. 20, 2002

Salicylate protects against the ototoxic and nephrotoxic side effects of cisplatin in rats

Aug. 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...